CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox (Q41755483)

8 October 2017

title

CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox (English)

1 reference

8 October 2017

0 references

0 references

1 reference

Kathleen Börner

1 reference

8 October 2017

Ellen Wiedtke

1 reference

8 October 2017

Dirk Grimm

1 reference

8 October 2017

Elena Senís

1 reference

8 October 2017

Chronis Fatouros

1 reference

8 October 2017

Stefanie Große

1 reference

8 October 2017

Dominik Niopek

1 reference

8 October 2017

Ann-Kristin Mueller

1 reference

8 October 2017

publication date

6 October 2014

1 reference

8 October 2017

published in

Biotechnology Journal

1 reference

8 October 2017

1 reference

8 October 2017

1 reference

8 October 2017

page(s)

1402-1412

1 reference

A guide to genome engineering with programmable nucleases

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

DNA DSB repair pathway choice: an orchestrated handover mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Multiplex genome engineering using CRISPR/Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

CRISPR-Cas systems for editing, regulating and targeting genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

RNA-guided genetic silencing systems in bacteria and archaea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Cas9 as a versatile tool for engineering biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Efficient genome editing in zebrafish using a CRISPR-Cas system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Genome-scale CRISPR-Cas9 knockout screening in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Genetic screens in human cells using the CRISPR-Cas9 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Oligomerized pool engineering (OPEN): an 'open-source' protocol for making customized zinc-finger arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Targeted gene disruption in somatic zebrafish cells using engineered TALENs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Production methods for gene transfer vectors based on adeno-associated virus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Novel tools for production and purification of recombinant adenoassociated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Current status of haemophilia gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Gene therapy for inherited retinal degenerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400046

21 January 2018

Identifiers

DOI

10.1002/BIOT.201400046

1 reference

8 October 2017

1 reference